ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1AChris T. Williamson, Christopher J. Lord, Rachel Brough et al.|Nature Communications|2016Cited by 386
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Johann S. de Bono, Adam Sharp et al.|Clinical Cancer Research|2018Cited by 158
β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive CarcinomaJeffrey C. Francis, Amanda Swain|PLoS Genetics|2013Cited by 99
HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumoursJeffrey C. Francis, Amanda Swain|British Journal of Cancer|2020Cited by 25